YO-01027

TargetMol
Product Code: TAR-T6135
Supplier: TargetMol
CodeSizePrice
TAR-T6135-1mg1mg£106.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6135-2mg2mg£120.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6135-5mg5mg£139.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6135-1mL1 mL * 10 mM (in DMSO)£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6135-10mg10mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6135-25mg25mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6135-50mg50mg£487.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
YO-01027 is a potent γ-secretase inhibitor.
CAS:
209984-56-5
Formula:
C26H23F2N3O3
Molecular Weight:
463.48
Pathway:
Neuroscience; Stem Cells; Proteases/Proteasome
Purity:
0.9956
SMILES:
C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O
Target:
Gamma-secretase

References

Liu L, Deng P, Liu S, et al.Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.Cell Death & Disease.2023, 14(8): 513. Groth C, et al, Mol Pharmacol, 2010, 77(4), 567-574. Xiong L, et al, Invest Ophthalmol Vis Sci, 2011, 52(8), 5641-5646. Harrison H, et al, Cancer Res, 2010, 70(2), 709-718. Van Es JH, et al, Nature, 2005, 435(7044), 959-963.